INNOVATIVE THINKING
RIGOROUS APPROACHES
REAL WORLD IMPACT

 

Dr. Ilene Harris

Dr. Harris (Ph.D., Epidemiology, and PharmD, University of Maryland, Baltimore) has more than 30 years of experience in geriatrics, medication use and quality, medication adherence, long-term care, dementia, traumatic brain injury and drug policy and program evaluation.

Dr. Harris’ research focuses on assessment of quality and appropriateness of care in long term care and community settings, care transitions into and out of nursing homes, and development of medication quality measures. She currently serves as the Project Director on a contract to evaluate the Maryland Multipayer Patient Centered Medical Home demonstration. She is Principal Investigator on a Cooperative Agreement with the US Food and Drug Administration’s Office of Generic Drugs to examine the utilization and switchback rates of brand versus generic drug products. She also has served as Principal Investigator on federally funded research that involve analyses of Medicare administrative data, including Parts A, B, D and Minimum Data Set assessment data, to study anticoagulation therapy after traumatic brain injury and to develop psychopharmacologic medication quality measures. In addition, she has participated in a research agenda to develop and validate claims-based measures of performance and functional status. Dr. Harris has over 100 publications in peer-reviewed journals.

Prior to joining IMPAQ, she was on the faculty of the University of Maryland, Baltimore, School of Pharmacy from 1983 to 2013. While there, she served as Chair of the Department of Pharmaceutical Health Services Research and as Associate Dean for Research and Graduate Education. As Professor Emeritus, she continues to mentor and teach graduate students. In 2007-2008, Dr. Harris was a Visiting Professor at Chulalongkorn University, Bangkok, Thailand through her assignment as a Senior Fulbright Scholar.

IMPAQ Papers and Presentations

Gill, C., Triebwasser, C., Perlman, E., Xu, L., Kiptanui, Z., Johnson, K., Cooke, C., & Harris, I. (2018, May). Capturing Enhanced MTM Services through Development of Encounter Data and Quality Indicator MeasuresPoster presentation at the Pharmacy Quality Alliance (PQA) Annual Meeting, Baltimore, MD. 

Kiptanui, Z., Dowell, P., Ogbenna, B., Desai, K., Zenilman, D., Harris, I., Qian, J., & Hansen, R. (2018, May). Consistency of Drug Labels for Therapeutically Equivalent Medications. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, Baltimore, MD. 

Perlman, E., Martin, B., Gall, E. & Harris, I. (2017, August). Inaccurate Online Provider Directories Linked to Beneficiary Harm. Presentation at the National Conference on Health Communication, Marketing, and Media, Atlanta, GA.

Perlman, E., Xu, L. & Harris, I. (2018, February). The Enhanced Medication Therapy Management Model. Poster at the Academy Health National Health Policy Conference, Washington DC.

Harris, I., Howard, J., Kiptanui, Z., Dong, J., Hesgrove, B. & Yoffe, M. (2017, June). Variations in Use of Generic Drugs by Patient Characteristics in the United States: Evidence from the Medical Expenditure Panel Survey, 2002-2013. Poster at the AcademyHealth Annual Research Meeting, New Orleans, LA.

Harris, I., Frank, G., Kiptanui, Z., Hansen, R., Mishuk, A., Qian, J. & Howard, J. (2017, May). The Association between Patient Sociodemographic Characteristics and Generic Drug Use- A Systematic Review and Meta-Analysis. Poster at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting, Boston.

Harris, I., Howard, J., Frank, G., Kiptanui, Z., Hansen, R. & Qian, J. (2017, July). Understanding Global Influencers of Generic Drug Use Among Older Adults. Poster at the International Association of Gerontology and Geriatrics (IAGG) World Congress, San Francisco, CA.

Xu, L., Harris, I., Kiptanui, Z. & Gill, C. (2017, November). Measurement of Healthcare Disparities- A Difference-in-difference-in-differences (DIDID) approach to Evaluate the Maryland Multi-Payor Patient Centered Medical Home Program.

Qian, J., Hansen, R., Harris, I., Kiptanui, Z., Howard, J., & Surry, D. (2017, August). Effects of Increasing Generic Drug Use on Medicare Prescription Plan Star Ratings. Poster at the International Conference on Pharmacoepidemiology, Montreal, Canada.

Kiptanui, Z., Ogbenna, B., Harris, I., Howard, J., Frank, G., Hansen, R. & Qian, J. (2017, November).  A Systematic Review of Generic Drug Substitution in Special Populations. Poster at the American Public Health Association (APHA) Annual Meeting and Expo, Atlanta, GA.

Howard, J., Frank, G., Kiptanui, Z., Qian, J., Hansen, R. & Harris, I. (2017, November). Identifying and Understanding Who and What Influences Generic Drug Utilization in the US. Poster at the American Public Health Association Annual Meeting, Atlanta, GA.

Kiptanui, Z., Ogbenna, B., Harris, I., Howard, J., Frank, G., Hansen, R. & Qian, J. (2017, November). Clinical Practice Patterns and Potential Barriers to Generic Drug Use in Special Populations. Poster at the American Public Health Association (APHA) Annual Meeting and Expo, Atlanta, GA.

Kiptanui, Z., Harris, I., Howard, J., Frank, G., Hansen, R. & Qian, J. (2017, November). Key Groups Influencing Generic Drug Use in the US: The Nature and Extent of Their Influence. Poster at the American Public Health Association (APHA) Annual Meeting and Expo, Atlanta, GA.

Harris, I. (2017, May). Key Groups Influencing Generic Drug Use in the U.S. and the Nature and Extent of Their Influence. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting, Boston, MA.